Stem cell therapy opens for brain injury patients in expanded access program
NCT ID NCT07164482
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 33 times
Summary
This expanded access program provides multiple intravenous doses of donor stem cells (HB-adMSCs) to up to 7 people with traumatic or non-traumatic brain injury who were not able to join the main study. The goal is to test safety and whether the treatment can help control the disease. Participants must be between 14 and 78 years old and have medical evidence of their brain injury from the past 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hope Biosciences Research Foundation
AVAILABLEHouston, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.